Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Amino acid structures inspire inhibitors of tau aggregation

Peptide inhibitors stop tau aggregation by capping fibril ends

by Celia Henry Arnaud
November 27, 2017 | APPEARED IN VOLUME 95, ISSUE 47

Credit: Nat. Chem.
Fibrils formed from a 10-amino-acid tau segment (alternating layers in green and blue), including the sequence VQIINK, form two zipper interfaces. The stick structures are shown with superimposed van der Waals radii.

Aggregates of a protein called tau are associated with many neurological disorders, including Alzheimer’s disease. Two six-amino acid segments of tau, which form structural motifs called steric zippers between adjacent protein strands in fibrils, cause tau aggregation. Those segments go by the names VQIVYK and VQIINK for the one-letter abbreviations of their constituent amino acids. David S. Eisenberg and coworkers at the University of California, Los Angeles, solved the structure of VQIVYK a decade ago (Nature 2007, DOI: 10.1038/nature05695). VQIINK formed crystals too small for conventional X-ray diffraction. Now, using microelectron diffraction, which works with nanometer-sized crystals, Eisenberg, postdoc Paul M. Seidler, and coworkers have solved crystal structures of VQIINK (Nat. Chem. 2017, DOI: 10.1038/nchem.2889). The new VQIINK structure reveals that it is a more powerful driver of tau aggregation and forms a larger zipper interface between strands than VQIVYK. In addition, the researchers show that a 10-amino acid peptide containing VQIINK simultaneously forms two zipper interfaces with different parts of the segment, which helps account for the improved fibril formation of VQIINK. The six-residue segment on its own forms yet another zipper interface. The researchers used the new structures to design peptides that inhibit tau aggregation by blocking the various interfaces and capping the ends of the fibrils. Also, the inhibitors block full-length tau fibrils from entering cells, which means they may be able to prevent the spread of tau aggregation in the brain.



This article has been sent to the following recipient:

Leave A Comment

*Required to comment